These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2320877

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Choosing topical corticosteroids.
    Ference JD, Last AR.
    Am Fam Physician; 2009 Jan 15; 79(2):135-40. PubMed ID: 19178066
    [Abstract] [Full Text] [Related]

  • 4. Cutaneous mast cell depletion results from topical corticosteroid usage.
    Lavker RM, Schechter NM.
    J Immunol; 1985 Oct 15; 135(4):2368-73. PubMed ID: 4031494
    [Abstract] [Full Text] [Related]

  • 5. Use and abuse of topical corticosteroids in infections of the skin and related structures.
    Wong VK, Della Croce C, Schonfeld S, Mastrangelo AM, Lebwohl M.
    J Drugs Dermatol; 2003 Jun 15; 2(3):268-76. PubMed ID: 12848111
    [Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory adrenal steroids that neither inhibit skin collagen synthesis nor cause dermal atrophy.
    DiPetrillo T, Lee H, Cutroneo KR.
    Arch Dermatol; 1984 Jul 15; 120(7):878-83. PubMed ID: 6547287
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Histology of skin changes caused by external corticoid preparations].
    Altmeyer P.
    Hautarzt; 1977 Feb 15; 28(2):83-8. PubMed ID: 403157
    [Abstract] [Full Text] [Related]

  • 10. [Age-dependent differences in the pharmacodynamic effect of topically applied Corticosteroids].
    Koch EM, Ott R, Koehler CO.
    Arzneimittelforschung; 1986 Oct 15; 36(10):1540-4. PubMed ID: 3814215
    [Abstract] [Full Text] [Related]

  • 11. Topical corticosteroids: mechanisms of action.
    Kragballe K.
    Acta Derm Venereol Suppl (Stockh); 1989 Oct 15; 151():7-10; discussion 47-52. PubMed ID: 2533778
    [Abstract] [Full Text] [Related]

  • 12. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
    Balkrishnan R, Camacho FT, Pearce DJ, Kulkarni AS, Spencer L, Fleischer AB, Feldman SR.
    J Drugs Dermatol; 2005 Oct 15; 4(6):699-706. PubMed ID: 16302555
    [Abstract] [Full Text] [Related]

  • 13. [Clinico-experimental testing for anti-inflammatory activity of external corticosteroids].
    Böttger E, Koch E, Tronnier H.
    Berufsdermatosen; 1977 Apr 15; 25(2):53-62. PubMed ID: 869888
    [Abstract] [Full Text] [Related]

  • 14. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y, Yoneda K, Nakai K, Katsuura J, Moriue T, Matsuoka Y, Miyamoto I, Ohya Y.
    J Am Acad Dermatol; 2009 Feb 15; 60(2):212-7. PubMed ID: 19027990
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Topical corticosteroids in dermatology.
    Tadicherla S, Ross K, Shenefelt PD, Fenske NA.
    J Drugs Dermatol; 2009 Dec 15; 8(12):1093-105. PubMed ID: 20027937
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The position not the presence of the halogen in corticosteroids influences potency and side effects.
    Bikowski J, Pillai R, Shroot B.
    J Drugs Dermatol; 2006 Feb 15; 5(2):125-30. PubMed ID: 16485880
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.